Australian-founded medical technology company SYMBYX today announced compelling results from a 72-week randomized controlled ...

This landmark trial is the largest-to-date and was only made possible because of the seminal work of Australian scientists from the ...

The drug will now progress to pivotal Phase III trials after demonstrating trends towards a disease-modifying impact.

Gibson's most famous moment came 37 years ago this month. Now he's leading another team towards a very different goal.

Ahead of Little Big Town's Nashville Christmas residency, the chart-topping country artist opens up about her mother's ...

Trials have shown the novel treatment appears to "reset" faulty wiring, helping patients move properly again - and early ...

A singing group is helping islanders with Parkinsons or dementia be more confident. The weekly singing sessions also help ...

Friends of a man living with Parkinson's disease have reunited to record a song he wrote more than 50 years ago. Dave Wells, ...

Parkinson’s — which can cause tremors, slow movement and stiffness — is believed to affect 1 in every 336 Americans.

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

Restless legs syndrome, a condition affecting millions of Americans, may be tied to increased Parkinson’s risk, according to ...

Parkinson’s is the fastest-growing neurodegenerative condition in the world, and the Coachella Valley is uniquely affected ...